<DOC>
	<DOCNO>NCT01914120</DOCNO>
	<brief_summary>The goal study ass quality life advance non-small cell lung cancer ( NSCLC ) patient undergo first-line chemotherapy , analyze current status tendency quality life ( QOL ) . The method use Functional Assessment Cancer Therapy-Lung ( FACT-L ) scale , ass quality life chemotherapy , 1st cycle chemotherapy 2nd cycle . After 3 time-points , investigator analyze subscales construct FACT-L . The assumption quality life well 2 cycle chemotherapy .</brief_summary>
	<brief_title>Quality Life Assessment Lung Cancer Patients China</brief_title>
	<detailed_description>1 . Lung cancer deadly cancer world , 85 % lung cancer non-small cell lung cancer ( NSCLC ) . The quality life NSCLC patient become important , NSCLC incurable . 2 . The recruitment take place 20 center country 500 patient enrol .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>age : &gt; 18 &lt; 75 year old pathological cytological diagnosis confirm advanced nonsmall cell lung cancer Eastern Cooperative Oncology Group Performance Status : 02 never receive kind anticancer chemotherapy agree regularly assessment quality life sign inform consent form Currently attend antitumor drug clinical trial Pregnancy breastfeed woman Currently receive antitumor chemotherapy , receive antitumor chemotherapy previously . suitable participate test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>lung cancer</keyword>
	<keyword>quality life</keyword>
	<keyword>FACT-L</keyword>
</DOC>